Healthtech Startups

Tuva provides infrastructure and data standardization solutions for healthcare analytics teams, enabling them to transform raw healthcare data into analysis-ready datasets. The platform serves healthcare organizations and data teams looking to reduce time spent rebuilding foundational data infrastructure.

5 investors

Two Chairs matches individuals with personalized mental health care, including therapy and psychiatry services, using a technology-enabled platform designed to improve access and treatment outcomes. The company serves people seeking affordable, evidence-based mental health care.

5 investors

Twosense uses passive biometrics and machine learning for continuous user authentication in enterprise environments, eliminating the need for passwords and physical tokens. The company serves enterprise customers and the US Department of Defense with automated identity verification software.

5 investors

TwoStep Therapeutics is a Stanford spinout developing targeted cancer therapies, including peptide-based drug conjugates and radioligand programs built on a tumor-targeting peptide platform. The company is advancing a preclinical pipeline toward a first clinical trial planned for the second half of 2026.

5 investors

Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.

5 investors

Uncovr builds a video-understanding foundation model that analyzes live surgical video to generate structured data for medical documentation and coding. The platform automates operative note generation and medical billing for hospitals and surgical centers.

5 investors

uniQure is a biotech company developing gene therapies for serious genetic diseases. The company's pipeline includes investigational treatments for conditions such as Huntington's disease, epilepsy, and Fabry disease.

5 investors

Upfront develops healthcare solutions that activate patients and improve clinical, financial, and operational outcomes for providers. The company combines healthcare expertise, technology, and behavioral science to address healthcare challenges.

5 investors

UpLift provides mental health and wellness services for college students through a referral platform connecting them with licensed providers and psychiatric care. The company offers flexible subscription and prepay models to ensure students can access treatment regardless of insurance status.

5 investors

Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.

5 investors

Validic operates a health IoT platform that connects over 700 medical devices and health apps to health systems, health plans, and life sciences organizations for clinical use. The company integrates siloed personal health data into actionable clinical workflows.

5 investors

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings. The company focuses on advancing coagulation therapy for patients taking this class of blood thinners.

5 investors

Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection. Its oral therapies target gut dysbiosis-driven conditions.

5 investors

Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.

5 investors

Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men. The therapy is being evaluated in Phase 2 and Phase 3 clinical trials.

5 investors

Veratrak provides data integration infrastructure for pharmaceutical supply chains, enabling manufacturers and distribution partners to share inventory, forecast, and shipment data through their existing communication channels. The platform ingests data from emails, spreadsheets, and APIs to create a unified, real-time view of external supply networks for early risk detection and coordination.

5 investors

VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.

5 investors

Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.

5 investors

VIDA provides imaging data collection and AI-powered analysis services to life sciences companies for accelerating drug development and clinical trials. The company serves therapeutic researchers and clinical development teams in the biotech and pharmaceutical sectors.

5 investors

Videa builds AI tools for dental clinicians to help identify, document, and communicate care while reducing operational burden in dental practices. The company applies artificial intelligence to dental diagnostics and care delivery to improve oral health at scale.

5 investors

ViewMind develops technology that provides objective, measurable data about brain function under cognitive stress to support clinical evaluation. The company's solution complements traditional biomarkers and imaging for healthcare providers.

5 investors

ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology. It operates in the AI-driven healthcare and diagnostics space.

5 investors

Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure. The company targets patients, surgeons, and healthcare facilities in the surgical robotics and medical device market.

5 investors

A company focused on improving understanding of energy-limiting, often invisible chronic conditions such as Long Covid and ME, which it states affect over 100 million people. Its stated aim is to support people living with these illnesses.

5 investors